| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |